Interventions for giggle incontinence: A scoping review of therapeutic strategies and outcomes.
Background: Giggle incontinence (GI) is a rare type of urinary incontinence that affects children and adolescents, impacting their quality of life by causing social isolation, reduced self-confidence, and low self-esteem. To counteract the symptoms of GI, various treatment approaches have been descr...
| Publicado en: | Indian Journal of Urology Vol. 42; no. 3; pp. 184 - 190 |
|---|---|
| Autores principales: | , , |
| Formato: | research systematic review tables/charts Journal Article |
| Publicado: |
Wolters Kluwer India Pvt Ltd
Jul-Sep2026
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=194976797&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 194976797 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 09701591 1KUG jtl: Indian Journal of Urology issn: 09701591 maglogo: N pubinfo: dt: Jul-Sep2026 vid: 42 iid: 3 pid: 16919 pub: Wolters Kluwer India Pvt Ltd artinfo: ui: 194976797 194976797 194976797 10.4103/iju.iju_401_25 194976797 ppf: 184 ppct: 6 formats: fmt: – @attributes: type: T – @attributes: type: P tig: atl: Interventions for giggle incontinence: A scoping review of therapeutic strategies and outcomes. aug: au: Bhavsar, Rutuben Harshadbhai Malik, Kritagya R. Kumar, Palani G. affil: College of Physiotherapy, Sumandeep Vidyapeeth Deemed to be University, Vadodara, Gujarat, India sug: subj: Therapeutics Urinary Incontinence Therapy Biofeedback Methylphenidate Therapeutic Use Behavior Modification Treatment Outcomes Patient Safety Human Scoping Review Adolescence Male Female Gray Literature Behavior Therapy Child PubMed Embase CINAHL Database Cochrane Library Life Style Changes Kegel Exercises Enuresis Therapy Adolescent: 13-18 years Child: 6-12 years Male Female ab: Background: Giggle incontinence (GI) is a rare type of urinary incontinence that affects children and adolescents, impacting their quality of life by causing social isolation, reduced self-confidence, and low self-esteem. To counteract the symptoms of GI, various treatment approaches have been described, but there is a dearth of reporting on their effectiveness. Objective: This review aims to synthesize evidence on the management of GI in the adolescent population, focusing on pharmacological and nonpharmacological interventions. Methods: Ascoping review was conducted using the Joanna Briggs Institute methodology and Preferred Reporting Items for Systematic Reviews and Meta-analyses extension for scoping reviews guidelines, along with the Population, Concept, Context framework, to perform a comprehensive search across major databases and gray literature. Treatment outcomes and follow-up data were extracted. Results: Of the 72 records, 9 studies met the inclusion criteria, in which the commonly used interventions were pharmacologic (mainly methylphenidate [MPH]) and nonpharmacologic (biofeedback, behavioral modifications). Studies explored the effectiveness of these interventions and found positive outcomes. Follow-up showed a significant effect of both the types of interventions. Conclusions: GI remains under-recognized in the adolescent population despite its effects on psychological and urological health. A multidisciplinary approach targeting the GI can help improve outcomes. This review provides insights about the use of various nonpharmacological therapies, such as biofeedback and behavioral therapy, and pharmacological therapies in the form of MPH to improve GI. Nonpharmacological approaches are low-risk and can be adapted as the primary treatment. Future research with planned methodology to compare the treatment efficacy is needed to improve the outcomes. pubtype: Academic Journal doctype: research systematic review tables/charts Journal Article ougenre: Article language: English refInfo: holdings: @attributes: islocal: N |
|---|